Key result
Chronic intermittent hypoxia during myocardial infarction exacerbated pathological remodeling and reduced survival by upregulating miR-214-3p and suppressing cardioprotective CTRP9 expression.
Why the study?
Whether and how chronic intermittent hypoxia affects cardiac remodeling following myocardial infarction remains unknown.
Does chronic intermittent hypoxia exacerbate post-MI remodeling, and can CTRP9 overexpression attenuate this effect in adult male mice?
Does chronic intermittent hypoxia exacerbate post-MI remodeling, and can CTRP9 overexpression attenuate this effect in adult male mice?
CIH exacerbates post-MI remodeling by upregulating miR-214-3p and suppressing the cardioprotective cardiokine CTRP9, suggesting CTRP9 as a potential therapeutic target for MI patients with sleep apnea.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for sleep apnea patients post-MI; leaves open CTRP9 modulation as therapy pending human trials.
Rationale: Obstructive sleep apnea-hypopnea syndrome, a sleep breathing disorder in which chronic intermittent hypoxia (CIH) is the primary pathology, is associated with multiple cardiovascular diseases. However, whether and how CIH may affect cardiac remodeling following myocardial infarction (MI) remains unknown. Objective: To determine whether CIH exposure at different periods of MI may exacerbate post-MI heart failure and to identify the mechanisms underlying CIH-exacerbated post-MI remodeling. Methods and Results: Adult male mice were subjected to MI (4 weeks) with and without CIH (4 or 8 weeks). CIH before MI (CIH+MI) had no significant effect on post-MI remodeling. However, double CIH exposure (CIH+MI+CIH) or CIH only during the MI period (MI+CIH) significantly exacerbated pathological remodeling and reduced survival rate. Mechanistically, CIH activated TGF-β (tumor growth factor-β)/Smad (homologs of both the Drosophila protein MAD and the C. elegans protein SMA) signaling and enhanced cardiac epithelial to mesenchymal transition, markedly increasing post-MI cardiac fibrosis. Transcriptome analysis revealed that, among 15 genes significantly downregulated (MI+CIH versus MI), Ctrp9 (a novel cardioprotective cardiokine) was one of the most significantly inhibited genes. Real-time polymerase chain reaction/Western analysis confirmed that cardiomyocyte CTRP9 expression was significantly reduced in MI+CIH mice. RNA-sequencing, real-time polymerase chain reaction, and dual-luciferase reporter assays identified that microRNA-214-3p is a novel Ctrp9 targeting miRNA. Its upregulation is responsible for Ctrp9 gene suppression in MI+CIH. Finally, AAV9 (adeno-associated virus 9)-mediated cardiac-specific CTRP9 overexpression or rCTRP9 (recombinated CTRP9) administration inhibited TGF-β/Smad and Wnt/β-catenin pathways, attenuated interstitial fibrosis, improved cardiac function, and enhanced survival rate in MI+CIH animals. Conclusions: This study provides the first evidence that MI+CIH upregulates miR-214-3p, suppresses cardiac CTRP9 (C1q tumor necrosis factor-related protein-9) expression, and exacerbates cardiac remodeling, suggesting that CTRP9 may be a novel therapeutic target against pathological remodeling in MI patients with obstructive sleep apnea-hypopnea syndrome.
No takes yet. Share an insight, caveat, or question.
Du et al. (2019) studied Myocardial infarction with chronic intermittent hypoxia. Chronic intermittent hypoxia (CIH) vs. MI without CIH was evaluated on Post-MI cardiac remodeling and survival rate. Chronic intermittent hypoxia during myocardial infarction exacerbated pathological remodeling and reduced survival by upregulating miR-214-3p and suppressing cardioprotective CTRP9 expression.
Synapse has enriched 10 related papers. Consider them for comparative context: